Severance Hospital

Seoul, Seoul Teugbyeolsi 3722

2 studies enrolling now · 3 studies all time

What they study most

Cancer Harboring BRAF Alterations, Diffuse Large B-Cell Lymphoma, HGG, High-grade B-cell Lymphoma, LGG, Mild Thrombocytopenia, Moderate Thrombocytopenia, Myelofibrosis, Solid Tumors

Studies at this site

• A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations — Recruiting now
• A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia — Recruiting now
• A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10) — Stopped early